Long COVID — the persistence of symptoms beyond four weeks after acute COVID-19 infection — has become one of the most significant public health challenges of our era. Estimates from the Office for National Statistics and similar bodies in other countries suggest millions of people globally are living with persistent post-COVID symptoms, with fatigue being the most commonly reported.
If you are experiencing post-COVID fatigue, you are not imagining it. It is real, it is recognised, and it is the subject of intensifying medical research.
Post-COVID fatigue is distinct from ordinary tiredness. Patients describe it as a profound, unrelenting exhaustion that is not relieved by rest — often accompanied by cognitive impairment (brain fog), sleep disturbance, breathlessness on minimal exertion, and a range of other symptoms affecting multiple organ systems.
A key feature that distinguishes severe long COVID fatigue from general tiredness is post-exertional malaise (PEM) — a worsening of symptoms following physical or cognitive effort that may not appear until 12–48 hours later and may persist for days or weeks. PEM is also the hallmark of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS), and many patients with severe long COVID meet diagnostic criteria for ME/CFS.
The mechanisms underlying long COVID fatigue are still being actively investigated. Current hypotheses include persistent viral reservoirs triggering ongoing immune activation, autoimmune processes, mitochondrial dysfunction impairing cellular energy production, autonomic nervous system dysregulation, and microbiome disruption. Most likely, several mechanisms operate simultaneously in different patients.
Persistent fatigue after COVID-19 requires medical assessment. A GP workup should include bloods (to exclude anaemia, thyroid dysfunction, vitamin deficiencies, and other treatable conditions), cardiac assessment if breathlessness is a feature, and screening for depression, which frequently co-exists with long COVID.
For patients with PEM, pacing is essential and potentially the single most important self-management intervention. Pacing means identifying your current energy envelope — the level of activity you can sustain without triggering PEM — and staying carefully within it. Activity logs, heart rate monitoring (keeping below approximately 60% of maximum heart rate), and structured rest periods are practical tools.
Crucially: conventional 'push through it' exercise approaches are not appropriate for patients with PEM and may cause significant harm. The approach that helps in simple deconditioning can worsen ME/CFS-type long COVID.
Sleep quality is frequently severely impaired in long COVID. CBT for Insomnia (CBT-I) has evidence for improving sleep in chronic conditions. Cognitive symptoms — brain fog, word-finding difficulties — benefit from cognitive load management: structuring demanding tasks, reducing multitasking, and allowing adequate recovery time after cognitive effort.
Specialist long COVID clinics — which exist in increasing numbers across the UK, Europe, and North America — bring together respiratory medicine, cardiology, physiotherapy, occupational therapy, and psychology to address the multi-system nature of the condition. Referral from a GP is typically the route of access.
Alongside fatigue, many long COVID patients experience significant musculoskeletal symptoms: widespread myalgia (muscle pain), joint pain, and body aches. These symptoms are real, frequently severe, and represent a significant component of disability for many patients.
Non-pharmacological pain management approaches — passive, low-effort strategies that do not trigger PEM — are particularly relevant for this patient group. Microcurrent electrotherapy involves placing electrode pads on painful areas and delivering gentle stimulation while the patient rests passively. The KFH Energy is FDA-cleared for pain relief (510(k) K073008) and may support management of the musculoskeletal pain component of long COVID.
To be explicit: KFH Energy is a pain relief device. Long COVID is not an approved indication. KFH Energy does not treat the underlying mechanisms of long COVID, does not address fatigue, and does not prevent PEM. Its role is specifically pain relief — for the muscle and joint pain symptoms that many long COVID patients experience. Its use should always be discussed with the treating clinician, particularly in the context of PEM, to ensure it fits within a safe and appropriate management plan.
Research into long COVID is moving rapidly. Clinical trials of several pharmacological and non-pharmacological interventions are ongoing. Biomarkers that could enable objective diagnosis and treatment monitoring are being identified. There is genuine momentum — and genuine reason for hope — even as the research is not yet where patients need it to be.
DISCLAIMER: Long COVID requires professional medical assessment and management. This article is for informational purposes only. Please consult your GP. KFH Energy is an FDA-cleared pain relief device (510(k) K073008) and is not a treatment for long COVID or post-exertional malaise. Individual results may vary.
